Research in Real-Life Ltd   Report issue

Foundation Phase 4
Founded: London United Kingdom (2001)

Organization Overview

First Clinical Trial
2014
NCT02294279
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Signs and Symptoms, Respiratory (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4